Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Doccole on Dec 11, 2020 5:17pm

Shares and deals

No question I am holding my shares right to the chest!

any comparables to a expected partnership out there?  It's easy if they sell the drug for 2b, then we know what to expect per share.  What about other deals? 


I don't know a lot about partnerships so any info is appreciated!  Bring 2021!

Comment by MrMugsy on Dec 11, 2020 6:40pm
Good question Doccole. As per Dan, we now have a 70% chance of a partnership. Here's my guess ... I would assume 3-4 partners in total ... one for Europe, one for USA, one for Japan and one for Rest-of-World (or something like that). Upfront cash to cover P3 and some cash in the bank. Royalties to be 10%-15%, depending on upfront cash outlay. These partners may also have right of first ...more  
Comment by Doccole on Dec 12, 2020 8:40am
Thanks for your thoughts Mugs.  I'm trying to figure out where the stock could realistically go.... Are you still Valuing our drug at 1 billion?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities